Skip to main content
SpringerLink
Log in

New Approaches for the Management of Dry Mouth in Sjögren’s Syndrome in Japan

  • Chapter
  • First Online:
Sjögren’s Syndrome

  • 1531 Accesses

Abstract

The management of xerostomia (dry mouth) in Sjögren’s syndrome includes rinsing of the mouth with water or mouthwash, the application of salivary substitutes and lubricants, and systemic secretagogues. There are three secretagogues suitable for alleviation of dry mouth in Sjögren’s syndrome patients in Japan. Because cevimeline is the most prevalent secretagogue now, we describe the prediction of the effect of cevimeline in patients with Sjögren’s syndrome. In addition, the usefulness of the mouth guard for prevention of hyperevaporation of saliva and immunological management are discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fox RI, Saito I. Criteria for diagnosis of Sjögren’s syndrome. Rheum Dis Clin North Am. 1994;20(2):391–407.

    PubMed  CAS  Google Scholar 

  2. Robinson PG, Pankhurst CL, Garrett EJ. Randomized-controlled trial: effect of a reservoir biteguard on quality of life in xerostomia. J Oral Pathol Med. 2005;34(4):193–7.

    Article  PubMed  Google Scholar 

  3. Frost PM, Gardner RM, Price AR, Sinclair GF. A preliminary assessment of intra-oral lubricating systems for dry mouth patients. Gerodontology 1997;14(1):54–8.

    Article  PubMed  CAS  Google Scholar 

  4. Frost PM, Shirlaw PJ, Challacombe SJ, Fernandes-Naglik L, Walter JD, Ide M. Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients. Oral Dis. 2006;12(1):57–62.

    Article  PubMed  CAS  Google Scholar 

  5. Frost PM, Shirlaw PJ, Walter JD, Challacombe SJ. Patient preferences in a preliminary study comparing an intra-oral lubricating device with the usual dry mouth lubricating methods. Br Dent J. 2002;193(7):403–8.

    Article  PubMed  CAS  Google Scholar 

  6. Fox PC. Salivary enhancement therapies. Caries Res. 2004;38(3):241–6.

    Article  PubMed  Google Scholar 

  7. Iwabuchi Y, Katagiri M, Masuhara T. Salivary secretion and histopathological effects after single administration of the muscarinic agonist SNI-2011 in MRL/lpr mice. Arch Int Pharmacodyn Ther. 1994;328(3):315–25.

    PubMed  CAS  Google Scholar 

  8. Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med. 2002;162(11):1293–300.

    Article  PubMed  CAS  Google Scholar 

  9. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum. 2002;46(3):748–54.

    Article  PubMed  CAS  Google Scholar 

  10. Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN, Smith PM. Antimuscarinic antibodies in primary Sjogren’s syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 2006;54(4):1165–73.

    Article  PubMed  CAS  Google Scholar 

  11. Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003;134(1):61–9.

    PubMed  Google Scholar 

  12. Yamamoto K, Nagashima H, Yamachika S, et al. The application of a night guard for sleep-related xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(3):e11–4.

    Article  PubMed  Google Scholar 

  13. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögrens syndrome (1999): availability and validity. Mod Rheumatol. 2004;14:425–34.

    Article  Google Scholar 

  14. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.

    Article  PubMed  CAS  Google Scholar 

  15. Yamada H, Nakagawa Y, Wakamatsu E, et al. Efficacy prediction of cevimeline in patients with Sjogren’s syndrome. Clin Rheumatol. 2007;26(8):1320–27.

    Article  PubMed  Google Scholar 

  16. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjogren’s syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974;37(2):217–29.

    Article  PubMed  CAS  Google Scholar 

  17. Rubin P, Holt JF. Secretory sialography in diseases of the major salivary glands. Am J Roentgenol Radium Ther Nucl Med. 1957;77(4):575–98.

    PubMed  CAS  Google Scholar 

  18. Edgar WM. Saliva: its secretion, composition and functions. Br Dent J. 1992;172(8):305–12.

    Article  PubMed  CAS  Google Scholar 

  19. Saito T, Fukuda H, Arisue M, et al. Relationship between sialographic findings of parotid glands and histopathologic finding of labial glands in Sjogren’s syndrome. Relation to clinical and immunologic findings. Oral Surg Oral Med Oral Pathol. 1991;72(6):675–80.

    Article  PubMed  CAS  Google Scholar 

  20. Rosas J, Ramos-Casals M, Ena J, et al. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjogren’s syndrome. Correlation with clinical, immunological and histological features. Rheumatology 2002;41(6):670–5.

    Article  PubMed  CAS  Google Scholar 

  21. Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med. 1999;159(2):174–81.

    Article  PubMed  CAS  Google Scholar 

  22. Papas AS, Sherrer YS, Charney M, et al. Successful treatment of dry mouth and dry eye symptoms in Sjogren’s Syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol. 2004;10(4):169–77.

    Article  PubMed  Google Scholar 

  23. Thie NM, Kato T, Bader G, Montplaisir JY, Lavigne GJ. The significance of saliva during sleep and the relevance of oromotor movements. Sleep Med Rev. 2002;6(3):213–27.

    Article  PubMed  Google Scholar 

  24. Lavigne GJ, Goulet JP, Zuconni M, Morrison F, Lobbezoo F. Sleep disorders and the dental patient: an overview. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(3):257–72.

    Article  PubMed  CAS  Google Scholar 

  25. Asplund R. Nocturia in the elderly in relation to thirst, dry mouth and dry eyes. Can J Urol. 2004;11(4):2322–6.

    PubMed  CAS  Google Scholar 

  26. Anderson DJ, Hector MP. Periodontal mechanoreceptors and parotid secretion in animals and man. J Dent Res. 1987;66(2):518–3.

    Article  PubMed  CAS  Google Scholar 

  27. Dawes C, Ong BY. Circadian rhythms in the flow rate and proportional contribution of parotid to whole saliva volume in man. Arch Oral Biol. 1973;18(9):1145–53.

    Article  PubMed  CAS  Google Scholar 

  28. Ferguson DB, Fort A. Circadian variations in human resting submandibular saliva flow rate and composition. Arch Oral Biol. 1974;19(1):47–5.

    Article  PubMed  CAS  Google Scholar 

  29. Edgar WE, O’Mullane DM. Saliva and oral health. 2nd ed. London: British Dental Association; 1996.

    Google Scholar 

  30. Wolff M, Kleinberg I. Oral mucosal wetness in hypo- and normosalivators. Arch Oral Biol. 1998;43(6):455–62.

    Article  PubMed  CAS  Google Scholar 

  31. Niedermeier W, Huber M, Fischer D, et al. Significance of saliva for the denture-wearing population. Gerodontology 2000;17(2):104–18.

    Article  PubMed  CAS  Google Scholar 

  32. Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB. Treatment of primary Sjogren’s syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group. J Interferon Cytokine Res. 1999;19(8):943–51.

    Article  PubMed  CAS  Google Scholar 

  33. Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary Sjogren’s syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum. 2003;49(4):585–93.

    Article  PubMed  CAS  Google Scholar 

  34. Pijpe J, van Imhoff GW, Spijkervet FK, et al. Rituximab treatment in patients with primary Sjogren’s syndrome: an open-label phase II study. Arthritis Rheum. 2005;52(9):2740–50.

    Article  PubMed  CAS  Google Scholar 

  35. Steinfeld SD, Tant L, Burmester GR, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren’s syndrome: an open-label phase I/II study. Arthritis Res Ther. 2006;8(4):R129.

    Article  PubMed  Google Scholar 

  36. Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren’s syndrome. Ann Rheum Dis. 1998;57(8):464–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Oral and Maxillofacial Surgery, Tsurumi University School of Dental Medicine, Yokohama, Japan

    Yoichi Nakagawa

  2. Department of Pathology, Tsurumi University School of Dental Medicine, Yokohama, Japan

    Ichiro Saito

Authors
  1. Yoichi Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ichiro Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ichiro Saito .

Editor information

Editors and Affiliations

  1. Research Foundation, Rheumatology Clinic, Scripps Memorial Hospital &, Caminito Sinnecock 6565, La Jolla, 92037, California, USA

    Robert I. Fox

  2. Research Foundation, Rheumatology Clinic, Scripps Memorial Hospital &, Caminito Sinnecock 6565, La Jolla, 92037, California, USA

    Carla M. Fox

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Nakagawa, Y., Saito, I. (2011). New Approaches for the Management of Dry Mouth in Sjögren’s Syndrome in Japan. In: Fox, R., Fox, C. (eds) Sjögren’s Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-957-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-957-4_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-60327-956-7

  • Online ISBN: 978-1-60327-957-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation